RASSF1A and RECK gene polymorphisms are risk factor for HCC in Egyptian population.
RASFA1 A1a/Ser, Ser/Ser genotypes and Ser allele are risk factor for HCC development.
A1a/Ser + GA haplotypes are risk factor for HCC development.
RECK GG, G allele and haplotype A1a/A1a + GG are protective to HCC.
HCC immune therapy can be modulated by these tumor suppressor gene polymorphisms.